Fulcrum Therapeutics (FULC) Stock Insights

FULC price $3.75 +0.05 +1.35%

Ticker
FULC
Price
$3.75
Change
+0.05 +1.35%
Market cap ?
$286.11M
P/E ?
-3.04
Dividend yield ?
0.00%
Beta ?
3.00
Sector
Healthcare
Industry
Biotechnology

Financials

201720182019202020212022202320242025
00088230001916300063420002805000800000000

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical firm committed to developing life-improving treatments for patients in the United States afflicted by genetically defined diseases with significant unmet medical needs. Its leading investigational therapies include losmapimod, a small molecule targeting facioscapulohumeral muscular dystrophy, and FTX-6058, an orally administered fetal hemoglobin…

Fair value

FULC fair value Not meaningful. Price $3.75.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare FULC

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—-0.07——
2026-07-30-0.34-0.24——
2026-04-27-0.25-0.31——
2026-02-24-0.31-0.31——
2025-10-29-0.31-0.29——
2025-07-29-0.28-0.29——
2025-05-01-0.28-0.29——
2025-02-25-0.31-0.28—142.86K
2024-11-13-0.35-0.41—112.50K
2024-07-310.87-0.0180.00M14.82M
2024-05-13-0.43-0.44—416.67K
2024-02-27-0.40-0.43871.00K552.72K
2023-11-07-0.39-0.43759.00K1.05M
2023-08-03-0.38-0.44880.00K1.12M
2023-05-15-0.41-0.46295.00K1.07M
2023-03-09-0.50-0.49685.00K1.89M
2022-11-08-0.51-0.611.18M2.54M
2022-08-11-0.83-0.661.88M2.96M
2022-05-09-0.64-0.632.59M3.94M
2022-03-03-0.58-0.735.06M2.68M
2021-11-04-0.57-0.654.93M2.25M
2021-08-10-0.60-0.624.38M1.60M
2021-05-06-0.54-0.664.79M5.66M
2021-03-04-0.64-0.724.22M1.31M
2020-11-10-0.70-0.651.85M1.71M
2020-08-11-0.66-0.782.00M2.36M
2020-05-13-0.81-0.75750.00K694.44K
2020-03-05-0.71-0.83——
2019-11-14-0.97-2.98——
2019-08-26-9.21-3.10——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-17TANG KEVINBuy50.95K$3.52179.33K
2026-07-16TANG KEVINBuy116.67K$3.56415.35K
2026-07-15TANG KEVINBuy107.38K$3.56382.26K
2026-07-14TANG KEVINBuy75.95K$3.58271.91K
2026-07-14TANG KEVINBuy53.65K$3.56191.00K
2026-07-13TANG KEVINBuy12.97K$3.5445.90K
2026-07-13TANG KEVINOther0——
2026-06-30Banks SonjaBuy32.00K$3.66117.12K
2026-06-30Dorton KatinaBuy32.00K$3.66117.12K
2026-06-30Gould Robert JBuy32.00K$3.66117.12K
2026-06-30Haviland KateBuy32.00K$3.66117.12K
2026-06-30King Rachel K.Buy32.00K$3.66117.12K
2026-06-30GERAGHTY JAMES ABuy32.00K$3.66117.12K
2026-06-30Hill ColinBuy32.00K$3.66117.12K
2026-06-30Ezekowitz AlanBuy32.00K$3.66117.12K
2026-06-26Ezekowitz AlanSell18.00K$3.6565.61K
2026-04-23Lehrer-Graiwer JoshuaBuy64.00K$8.08517.12K
2026-04-23Lehrer-Graiwer JoshuaOther0——
2026-02-02Musso Alan ABuy170.00K$10.721.82M
2026-02-02Oltmans Curtis GaleBuy170.00K$10.721.82M
2026-02-02Gould Robert JSell15.00K$10.72160.86K
2026-02-02Tourangeau GregBuy57.00K$10.72611.04K
2026-02-02Sapir AlexBuy650.00K$10.726.97M
2026-01-02Gould Robert JSell15.00K$10.87163.09K
2026-01-02Gould Robert JSell15.00K$11.87178.09K
2025-12-15Oltmans Curtis GaleSell3.45K$12.9244.60K
2025-12-08RA CAPITAL MANAGEMENT, L.P.Sell1.38M$13.3318.36M
2025-12-08RA CAPITAL MANAGEMENT, L.P.Sell2.71M$14.2838.65M
2025-12-08RA CAPITAL MANAGEMENT, L.P.Sell91.72K$14.981.37M
2025-11-19Gould Robert JSell15.00K$11.03165.50K
2025-06-26GERAGHTY JAMES ABuy36.00K$7.38265.68K
2025-06-26Dorton KatinaBuy36.00K$7.38265.68K
2025-06-26Haviland KateBuy36.00K$7.38265.68K
2025-06-26King Rachel K.Buy36.00K$7.38265.68K
2025-06-26Hill ColinBuy36.00K$7.38265.68K
2025-06-26Banks SonjaBuy36.00K$7.38265.68K
2025-06-26Gould Robert JBuy36.00K$7.38265.68K
2025-06-26Ezekowitz AlanBuy36.00K$7.38265.68K
2025-05-08Tourangeau GregSell498$5.062.52K
2025-01-24Musso Alan ABuy285.00K$4.161.19M
2025-01-24Sapir AlexBuy582.00K$4.162.42M
2025-01-24Tourangeau GregBuy76.12K$4.16316.66K
2025-01-24Oltmans Curtis GaleBuy225.00K$4.16936.00K
2024-11-12King Rachel K.Buy60.00K$3.64218.40K
2024-11-12King Rachel K.Other0——
2024-09-12RA CAPITAL MANAGEMENT, L.P.Other0——
2024-09-12RA CAPITAL MANAGEMENT, L.P.Other8.50M$0.008.50K
2024-08-21RA CAPITAL MANAGEMENT, L.P.Buy8.50M$0.008.50K
2024-08-21RA CAPITAL MANAGEMENT, L.P.Sell8.50M$0.008.50K
2024-07-03Sapir AlexSell150.00K$3.27490.50K
2024-07-03Sapir AlexBuy150.00K$3.27490.50K
2024-06-17Ezekowitz AlanBuy30.00K$7.00210.00K
2024-06-17Gould Robert JBuy30.00K$7.00210.00K
2024-06-17Haviland KateBuy30.00K$7.00210.00K
2024-06-17GERAGHTY JAMES ABuy30.00K$7.00210.00K
2024-06-17Dorton KatinaBuy30.00K$7.00210.00K
2024-06-17Collins James J.Buy30.00K$7.00210.00K
2024-06-17Banks SonjaBuy30.00K$7.00210.00K
2024-06-17Hill ColinBuy60.00K$7.00420.00K
2024-06-17Hill ColinSell0——
2024-05-07Tourangeau GregSell236$7.761.83K
2024-03-18Horn Patrick TaylorBuy400.00K$10.124.05M
2024-03-18Horn Patrick TaylorSell0——
2024-03-08Tourangeau GregSell4.88K$11.7257.22K
2024-03-04Sapir AlexBuy43.36K$11.35492.03K
2024-01-26Tourangeau GregBuy83.82K$6.95582.55K
2024-01-26Tourangeau GregBuy10.00K$6.9569.50K
2024-01-26Musso Alan ABuy100.00K$6.95695.00K
2024-01-26Oltmans Curtis GaleBuy150.00K$6.951.04M
2024-01-17Musso Alan ABuy61.82K$4.01247.91K
2023-08-07Musso Alan ABuy432.80K$4.011.74M
2023-08-07Musso Alan ASell0——
2023-07-01Sapir AlexSell2.43M$3.277.95M
2023-06-27GERAGHTY JAMES ABuy30.00K$3.1694.80K
2023-06-27Haviland KateBuy30.00K$3.1694.80K
2023-06-27Dorton KatinaBuy30.00K$3.1694.80K
2023-06-27Banks SonjaBuy30.00K$3.1694.80K
2023-06-27Ezekowitz AlanBuy30.00K$3.1694.80K
2023-06-27Gould Robert JBuy30.00K$3.1694.80K
2023-06-27Collins James J.Buy30.00K$3.1694.80K
2023-05-10Tourangeau GregSell210$3.31695
2023-04-26Hayes Melvin H. IIIBuy115.00K$2.58296.70K
2023-04-26Oltmans Curtis GaleBuy127.50K$2.58328.95K
2023-02-09Oltmans Curtis GaleBuy150.00K$12.591.89M
2023-02-09Tourangeau GregBuy16.10K$12.59202.70K
2023-02-09Hayes Melvin H. IIIBuy135.00K$12.591.70M
2023-02-09Rajavelu EstherBuy160.00K$12.592.01M
2023-01-20RA CAPITAL MANAGEMENT, L.P.Buy1.92M$13.0025.00M
2023-01-13Gould Robert JSell6.77K$15.00101.49K
2023-01-04RA CAPITAL MANAGEMENT, L.P.Buy58.37K$7.80455.09K
2023-01-04RA CAPITAL MANAGEMENT, L.P.Buy122.33K$7.03859.71K
2022-12-27RA CAPITAL MANAGEMENT, L.P.Buy4.09K$5.9924.51K
2022-12-19RA CAPITAL MANAGEMENT, L.P.Buy98.79K$5.90582.81K
2022-12-16RA CAPITAL MANAGEMENT, L.P.Buy1.34M$5.427.27M
2022-12-15RA CAPITAL MANAGEMENT, L.P.Buy237.03K$5.501.30M
2022-12-14RA CAPITAL MANAGEMENT, L.P.Buy824.60K$5.464.50M
2022-12-13Third Rock Ventures III, L.P.Sell2.00M——
2022-11-07Arroyo SantiagoBuy400.00K——
2022-11-07Arroyo SantiagoSell0——
2022-08-16RA CAPITAL MANAGEMENT, L.P.Other0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 163, holders -12 vs prior quarter. Ownership 104.80%.

HolderSharesChangeChange %Value
BLACKROCK, INC.8.82M3.43M+63.70%32.30M
ECOR1 CAPITAL, LLC6.55M6.55MNew23.97M
TANG CAPITAL MANAGEMENT LLC6.52M6.52MNew23.87M
NANTAHALA CAPITAL MANAGEMENT, LLC5.48M2.42M+79.51%20.04M
MONTANOVA CAPITAL, LLC3.68M-2.88M-43.90%13.47M
D. E. SHAW & CO., INC.3.04M1.42M+87.55%11.14M
CITADEL ADVISORS LLC2.70M2.67M+7170.17%9.90M
VANGUARD CAPITAL MANAGEMENT LLC2.70M4.27K+0.16%9.87M
JANE STREET GROUP, LLC2.22M1.91M+614.36%8.12M
STATE STREET CORP2.04M487.17K+31.43%7.46M
ADAGE CAPITAL PARTNERS GP, L.L.C.2.00M1.60M+400.00%7.32M
GSK PLC1.79M00.00%6.54M
QUBE RESEARCH & TECHNOLOGIES LTD1.75M773.73K+79.38%6.40M
RENAISSANCE TECHNOLOGIES LLC1.65M1.65MNew6.03M
ADAR1 CAPITAL MANAGEMENT, LLC1.57M1.43M+1098.70%5.73M
MILLENNIUM MANAGEMENT LLC1.49M1.13M+316.81%5.44M
GEODE CAPITAL MANAGEMENT, LLC1.43M-54.41K-3.66%5.24M
MARSHALL WACE, LLP1.36M1.36MNew4.97M
UBS GROUP AG1.25M938.72K+297.83%4.59M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.18M1.10M+1310.93%4.32M
AQR CAPITAL MANAGEMENT LLC1.10M560.10K+103.12%4.04M
GOLDMAN SACHS GROUP INC1.09M522.52K+91.36%4.01M
IKARIAN CAPITAL, LLC1.05M00.00%3.84M
BANK OF AMERICA CORP /DE/1.04M916.47K+724.14%3.82M
ACADIAN ASSET MANAGEMENT LLC1.04M311.48K+42.83%3.79M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Fulcrum Therapeutics (FULC) Stock Insights

FULC$3.75+0.05 +1.35%

$286.11M

Market Cap

-3.04

P/E

—

Forward P/E

—

Score

Price History